Skip to main content
Equibles

DRUG · Bright Minds Biosciences Inc.

Track DRUG — free

Use DRUG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DRUG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$63.18 -1.82 (-2.80%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$619.93M
Shares
9.81M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$63.18 Open$66.25 Day$62.42–66.25 52W close$44.68–95.99 Avg vol 30d132K Short int894K · 9.1% float · 7.1d Short vol38% Last earningsJan 6, 2026 DataJul 2023–Sep 2026

Raw chart and full-history price indicators begin at the captured split on Jul 14, 2023; bars on opposite sides are not compared.

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+27.9%
Trailing year
Short interest
9.1%
Latest settlement · 7.1 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bullish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.60
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −19%
below
Price vs 50-day avg −15%
below
RSI (14) 31
neutral
MACD trend Negative
52-week position 36%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −19%
trailing
6-month return −12%
trailing
YTD return −19%
this year
Relative strength −30%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $74 › 200d $78 — 200d above 50d
Institutional flow Accumulating
+5% holders QoQ · +19 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
9.11% of float · ▼ -0.4% MoM · 7.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
99 holders — near 3-yr high, broad support
Squeeze score 65
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 66%
annualized · 1-yr
Max drawdown −38%
past year
ATR 5.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 4 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−19% Bearish
Price vs 50-day avg
−15% Bearish
RSI (14)
31 Neutral
MACD trend
Negative Bearish
52-week position
36% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $74 › 200d $78 — 200d above 50d
Institutional flow Accumulating
+5% holders QoQ · +19 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
9.11% of float · ▼ -0.4% MoM · 7.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
99 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $45 Now $63 · 36% Range high $96
vs 200-day avg -19% vs 50-day avg -15%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
DRUG
Bright Minds Biosciences Inc.
this stock
$619.93M -19.0% — — 9.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.64B +13.7% +46.2% 30.0 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $80.46B +1.2% +20.8% 19.4 2.5%
ARGX
Argenx SE
 $61.22B +17.1% — — 2.0%
MRNA
Moderna, Inc.
 $57.48B +388.2% +4.3% — 9.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
99
% held
94.9%
Net QoQ
+122.6K sh
Top holder
Jupiter Topco LLC
Held Float
View
Held by Funds
Fund positions
90
View
Short & Settlement
Short Interest Falling
Shares short
893.6K
Days to cover
7.1d
Change
-3.7K sh
View
Short Volume
Short vol %
38%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
9
Value
$714
As of
Aug 10, 2026
View
Off-Exchange
Off-exchange %
37.7%
Week of
Aug 3, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 17, 2026
This year
13
View
Exempt Offerings
Offering
$34.6M
Filed
Nov 19, 2024
View
Earnings & Events
Earnings Calls
Last call
Jan 6, 2026
View

Performance

Raw-price comparisons begin at the captured split on Jul 14, 2023; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
DRUG -7.1% -19.0% -11.8% -11.9% -19.0%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -6.0% -17.3% -29.6% -11.6% -31.1%
Key facts CIK 1827401 CUSIP 10919W405 13F (30d) 68 filings 68 filers Visit website Investor relations